Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec 1;34(6):619-626.
doi: 10.1097/QCO.0000000000000776.

How different is invasive fusariosis in pediatric patients than in adults? A systematic review

Luana Rossato  1 , Fabianne Carlesse  2   3 , João Nobrega de Almeida Jr  1   4 , Dimitrios P Kontoyiannis  5 , Arnaldo Lopes Colombo  1
Affiliations
Case Reports

How different is invasive fusariosis in pediatric patients than in adults? A systematic review

Luana Rossato et al. Curr Opin Infect Dis. .

Abstract

Purpose of review: To investigate the peculiarities of invasive fusariosis (IF) in pediatric patients.

Methods: We conducted a systematic literature review to identify human cases of locally invasive and systemic fusariosis documented in children (up to 18 years) published between 1973 (first case report) and 2021.

Recent findings: One hundred and six cases were retrieved, and hematologic malignancy was reported in 64% (68/106) of the cases. The most frequent anatomic sites involved were skin 66% (70/106), blood 47% (50/106), and lungs 35% (37/106), bone and joint (8%, 09/106), and eye/central nervous system involvement (8%, 9/106). Fusarium solani, followed by Fusarium oxysporum, were the most commonly reported species. In disseminated fusariosis, relapsed or refractory baseline disease (P < 0.001, OR=10.555, CI 95% 3.552-31.365) was associated with poor outcome, whereas voriconazole-based therapy was associated with better prognosis (P = 0.04, OR = 0.273, CI 95% 0.076-0.978).

Summary: Hematologic malignancies and solid tumors requiring intensive immunosuppression are the main conditions related to IF in children where other organs than skin, blood, and lungs were frequently involved. Voriconazole therapy appears to be also effective in children with IF, despite the wide pharmacokinetic variability of this triazole in pediatric patients.

PubMed Disclaimer

References

    1. Rosanova María Teresa, Brizuela Martín, Villasboas Mabel, et al. Fusarium spp infections in a pediatric burn unit: nine years of experience. Braz J Infect Dis 2016; 20:389–392.
    1. Hassler Angela, Lieb Adrian, Seidel Danila, et al. Disseminated fusariosis in immunocompromised children - Analysis of recent cases identified in the global fungiscope registry. Pediatr Infect Dis J 2017; 36:230–231.
    1. Summerell Brett A. Resolving fusarium: current status of the genus. Ann Rev Phytopathol 2019; 57:323–339.
    1. Al-Hatmi Abdullah MS, Bonifaz Alexandro, Ranque Stephane, et al. Current antifungal treatment of fusariosis. Int J Antimicrob Agents 2018; 51:326–332.
    1. Velasco E, Martins CA, Nucci M. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis 1995; 14:697–699.

Publication types